Paperpal Prime Logo

Cellular and Molecular Immunology : Impact Factor & More

eISSN: 2042-0226pISSN: 1672-7681

Key Metrics

CiteScore
14.2
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
SJR
Q1Immunology
SNIP
2.08
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cellular and Molecular Immunology

Cellular and Molecular Immunology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher CHIN SOCIETY IMMUNOLOGY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2004
Website URLVisit website
View less

Planning to publish in Cellular and Molecular Immunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cellular and Molecular Immunology

Targeting SPP1 requires moving beyond ligand blockade.
  • 1 Aug 2026
  • Cellular & molecular immunology
FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.
  • 1 Aug 2026
  • Cellular & molecular immunology
Sympathetic immunomodulation suppresses liver metastasis by maintaining the balance between norepinephrine concentration and the α2a/β2-AR ratio.
  • 1 Aug 2026
  • Cellular & molecular immunology
A cholinergic checkpoint controls autoantibody selection via somatic hypermutation in lupus germinal centers.
  • 1 Aug 2026
  • Cellular & molecular immunology
Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis.
  • 1 Aug 2026
  • Cellular & molecular immunology
Platelet-derived serotonin epigenetically programs macrophage alternative activation to orchestrate type 2 airway inflammation.
  • 30 Jul 2026
  • Cellular & molecular immunology
Targeting SPP1 requires moving beyond ligand blockade.
  • 1 Aug 2026
  • Cellular & molecular immunology
FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.
  • 1 Aug 2026
  • Cellular & molecular immunology
Sympathetic immunomodulation suppresses liver metastasis by maintaining the balance between norepinephrine concentration and the α2a/β2-AR ratio.
  • 1 Aug 2026
  • Cellular & molecular immunology
A cholinergic checkpoint controls autoantibody selection via somatic hypermutation in lupus germinal centers.
  • 1 Aug 2026
  • Cellular & molecular immunology
Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis.
  • 1 Aug 2026
  • Cellular & molecular immunology
Platelet-derived serotonin epigenetically programs macrophage alternative activation to orchestrate type 2 airway inflammation.
  • 30 Jul 2026
  • Cellular & molecular immunology

FAQs on Cellular and Molecular Immunology